Skip to content
10-Q

Quarterly Report

Grace Therapeutics, Inc. GRCE

0001140361-25-041804

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2026 · Sep 30, 2025 15.92M sh
Shares Diluted Q2 2026 · Sep 30, 2025 15.92M sh
Shares Diluted Q2 2026 · Sep 30, 2024 11.51M sh
Shares Diluted Q2 2026 · Sep 30, 2024 11.51M sh
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$4.94M
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$7.84M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $16.86M
Cash And Equivalents Q2 2026 · Mar 31, 2025 $22.13M
Stockholders Equity Q2 2026 · Sep 30, 2025 $62.82M
Stockholders Equity Q2 2026 · Jun 30, 2025 $63.55M
Stockholders Equity Q2 2026 · Mar 31, 2025 $66.61M
Stockholders Equity Q2 2026 · Sep 30, 2024 $56.13M
Stockholders Equity Q2 2026 · Jun 30, 2024 $59.36M
Stockholders Equity Q2 2026 · Mar 31, 2024 $61.74M
Current Liabilities Q2 2026 · Sep 30, 2025 $1.25M
Current Liabilities Q2 2026 · Mar 31, 2025 $1.93M
Total Liabilities Q2 2026 · Sep 30, 2025 $3.76M
Total Liabilities Q2 2026 · Mar 31, 2025 $5.38M
Current Assets Q2 2026 · Sep 30, 2025 $17.3M
Current Assets Q2 2026 · Mar 31, 2025 $22.71M
Total Assets Q2 2026 · Sep 30, 2025 $66.58M
Total Assets Q2 2026 · Mar 31, 2025 $71.99M
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.06
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.27
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.30
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.53
Eps Basic Q2 2026 · Sep 30, 2025 −$0.06
Eps Basic Q2 2026 · Sep 30, 2025 −$0.27
Eps Basic Q2 2026 · Sep 30, 2024 −$0.30
Eps Basic Q2 2026 · Sep 30, 2024 −$0.53
Sga Expense Q2 2026 · Sep 30, 2025 $1.96M
Sga Expense Q2 2026 · Sep 30, 2025 $4.1M
Sga Expense Q2 2026 · Sep 30, 2024 $1.86M
Sga Expense Q2 2026 · Sep 30, 2024 $4.11M
Rd Expense Q2 2026 · Sep 30, 2025 $568K
Rd Expense Q2 2026 · Sep 30, 2025 $1.52M
Rd Expense Q2 2026 · Sep 30, 2024 $2.98M
Rd Expense Q2 2026 · Sep 30, 2024 $5.68M
Net Income Q2 2026 · Sep 30, 2025 −$938K
Net Income Q2 2026 · Sep 30, 2025 −$4.3M
Net Income Q2 2026 · Jun 30, 2025 −$3.36M
Net Income Q2 2026 · Sep 30, 2024 −$3.43M
Net Income Q2 2026 · Sep 30, 2024 −$6.05M
Net Income Q2 2026 · Jun 30, 2024 −$2.62M
Operating Income Q2 2026 · Sep 30, 2025 −$2.53M
Operating Income Q2 2026 · Sep 30, 2025 −$5.62M
Operating Income Q2 2026 · Sep 30, 2024 −$4.83M
Operating Income Q2 2026 · Sep 30, 2024 −$9.79M